Prognostic Implications of Clinical, Laboratory and Echocardiographic Biomarkers in Patients with Acute Myocardial Infarction-Rationale and Design of the ''CLEAR-AMI Study''.
Stylianos DaiosVasileios AnastasiouDimitrios V MoysidisMatthaios DidagelosΑndreas S PapazoglouNikolaos StalikasThomas ZegkosEfstratios KaragiannidisLemonia SkouraGeorgia KaiafaKali MakedouAntonios ZiakasChristos SavopoulosVassilios KamperidisPublished in: Journal of clinical medicine (2023)
The ''CLEAR-AMI" study is an ongoing prospective registry endeavoring to refine risk assessment in patients with AMI without a known history of coronary artery disease, by incorporating echocardiographic parameters, biochemical indices, and clinical and coronary characteristics in the acute phase of AMI.